Abstract
Background
Osteoporosis is a disease of the bones leading to decreased bone mineral density, leading to fragility fractures. This article is an overview of osteoporosis, osteomalacia and fragility fractures and serves as an introductory article for this special issue on osteoporosis.
Methods
This is a short, comprehensive account of the given conditions with concepts and a review from the recent literature. The authors provide relevant references from the literature in the bibliography. The sections herein have also been deliberated in the meetings of experts of osteoporosis.
Results
An overview of osteoporosis, osteomalacia and fragility fractures is provided, including definitions and summaries of aetiology, pathophysiology, diagnosis, prevention, and management. A detailed account of some of these topics will be provided in subsequent chapters.
Conclusion
Osteoporosis is a silent disease with the potential to cause significant morbidity and mortality if not detected early. It is important to differentiate from and diagnose associated osteomalacia to provide accurate therapy. It is also important to identify the type of fragility fractures and initiate treatment for bone strengthening to prevent subsequent fractures.
Similar content being viewed by others
References
Sözen, T., Özışık, L., & Başaran, N. Ç. (2017). An overview and management of osteoporosis. European Journal of Rheumatology, 4(1), 46–56.
Clynes, M. A., Harvey, N. C., Curtis, E. M., Fuggle, N. R., Dennison, E. M., & Cooper, C. (2020). The epidemiology of osteoporosis. British Medical Bulletin, 133(1), 105–117.
Salari, N., Ghasemi, H., Mohammadi, L., et al. (2021). The global prevalence of osteoporosis in the world: A comprehensive systematic review and meta-analysis. Journal of Orthopaedic Surgery and Research, 16, 609.
Dobbs, M. B., Buckwalter, J., & Saltzman, C. (1999). Osteoporosis: The increasing role of the orthopaedist. Iowa Orthopaedic Journal, 19, 43–52.
Conference, C. (1984). Osteoporosis. Journal of the American Medical Association, 252, 799.
Anonymous WHO Study Group. (1994). Assessment of fracture risk and its application to screening for post-menopausal osteoporosis. WHO.
Office of the Surgeon G. (2004). Reports of the Surgeon General. Bone health and osteoporosis: A report of the surgeon general. Office of the Surgeon General (US).
Downey, P. A., & Siegel, M. I. (2006). Bone biology and the clinical implications for osteoporosis. Physical Therapy, 86(1), 77–91.
Berger, C., Langsetmo, L., Joseph, L., Hanley, D. A., Canadian Multicentre Osteoporosis Study Research Group, et al. (2008). Change in bone mineral density as a function of age in women and men and association with the use of antiresorptive agents. CMAJ, 178(13), 1660–1668.
Greenstein, A. S., & Gorczyca, J. T. (2019). Orthopedic surgery and the geriatric patient. Clinics in Geriatric Medicine, 35(1), 65–92.
Carey, J. J., Wu, P. C., & Bergin, D. (2022). Risk assessment tools for osteoporosis and fractures in 2022. Best Practice & Research Clinical Rheumatology, 36(3), 101775.
Fathima, S. N., Tamilselvi, R., & Beham, M. P. (2020). Measurement of BMD in dual-energy X-ray absorptiometry—A review. International Research Journal of Innovations in Engineering and Technology., 4(3), 13.
Lewiecki, E. M. (2022). Evaluating patients for secondary causes of osteoporosis. Current Osteoporosis Reports, 15, 1–2.
Burden, A. M., Tanaka, Y., Xu, L., Ha, Y. C., McCloskey, E., Cummings, S. R., & Glüer, C. C. (2020). Osteoporosis case ascertainment strategies in European and Asian countries: A comparative review. Osteoporosis International. https://doi.org/10.1007/s00198-020-05756-8
Kanis, J. A., Harvey, N. C., Johansson, H., Liu, E., Vandenput, L., Lorentzon, M., Leslie, W. D., & McCloskey, E. V. (2020). A decade of FRAX: How has it changed the management of osteoporosis? Aging Clinical and Experimental Research, 32, 187–196.
Chiodini, I., Merlotti, D., Falchetti, A., & Gennari, L. (2020). Treatment options of glucocorticoid-induced osteoporosis. Expert OpinPharmacother., 21, 721–732.
Francis, R. M., & Selby, P. L. (1997). Osteomalacia. Baillieres Clinical Endocrinology and Metabolism, 11(1), 145–163.
Arboleya, L., Braña, I., Pardo, E., Loredo, M., & Queiro, R. (2023). Osteomalacia in adults: A practical insight for clinicians. Journal of Clinical Medicine, 12(7), 2714.
Uday, S., & Högler, W. (2020). Nutritional rickets & osteomalacia: A practical approach to management. The Indian Journal of Medical Research, 152(4), 356.
Janoušek, J., Pilařová, V., Macáková, K., Nomura, A., Veiga-Matos, J., da Silva, D. D., Remião, F., Saso, L., Malá-Ládová, K., Malý, J., et al. (2022). Vitamin D: Sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Critical Reviews in Clinical Laboratory Sciences, 59, 517–554.
Peacock, M. (2021). Phosphate metabolism in health and disease. Calcified Tissue International, 108, 3–15.
Cianferotti, L. (2022). Osteomalacia is not a single disease. International Journal of Molecular Sciences, 23(23), 14896. https://doi.org/10.3390/ijms232314896
Bhan, A., Qiu, S., & Rao, S. D. (2018). Bone histomorphometry in the evaluation of osteomalacia. Bone Reports, 17(8), 125–134.
Dempster, D. W., Compston, J. E., Drezner, M. K., et al. (2013). Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. Journal of Bone and Mineral Research, 28(1), 2–17.
Florenzano, P., Gafni, R. I., & Collins, M. T. (2017). Tumor-induced osteomalacia. Bone Reports, 20(7), 90–97.
Brown, J. P., & Josse, R. G. (2002). Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. Canadian Medical Association Journal, 67(10 Suppl), S1–S34.
Kanis, J. A., et al. (2001). The burden of osteoporotic fractures: A method for setting intervention thresholds. Osteoporosis International, 12(5), 417–427.
Acevedo, C., Stadelmann, V. A., Pioletti, D. P., Alliston, T., & Ritchie, R. O. (2018). Fatigue as the missing link between bone fragility and fracture. Nature Biomedical Engineering, 2, 62–71.
Melton, L. J., Achenbach, S. J., Atkinson, E. J., Therneau, T. M., & Amin, S. (2013). Long-term mortality following fractures at different skeletal sites: A population-based cohort study. Osteoporosis International, 24, 1689–1696.
Watts, N. B. (2014). GLOW investigators insights from the global longitudinal study of osteoporosis in women (GLOW). Nature Reviews Endocrinology, 10, 412–422.
Kannegaard, P. N., van der Mark, S., Eiken, P., & Abrahamsen, B. (2010). Excess mortality in men compared with women following a hip fracture. national analysis of comedications, comorbidity and survival. Age and Ageing, 39, 203–209.
Jansson, K.-A., Blomqvist, P., Svedmark, P., Granath, F., Buskens, E., Larsson, M., & Adami, J. (2010). Thoracolumbar vertebral fractures in Sweden: An analysis of 13,496 patients admitted to hospital. European Journal of Epidemiology, 25, 431–437.
Trajanoska, K., & Rivadeneira, F. (2019). The genetic architecture of osteoporosis and fracture risk. Bone, 126, 2–10.
Burger, H., de Laet, C. E., van Daele, P. L., Weel, A. E., Witteman, J. C., Hofman, A., & Pols, H. A. (1998). Risk factors for increased bone loss in an elderly population: The Rotterdam study. American Journal of Epidemiology, 147, 871–879.
Johnell, O., & Kanis, J. A. (2004). An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporosis International, 15, 897–902.
Winner, S. J., Morgan, C. A., & Evans, J. G. (1989). Perimenopausal risk of falling and incidence of distal forearm fracture. BMJ, 298, 1486–1488.
Corso, P., Finkelstein, E., Miller, T., Fiebelkorn, I., & Zaloshnja, E. (2015). Incidence and lifetime costs of injuries in the United States. Injury Prevention, 21, 434–440.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
On behalf of all authors, the corresponding author states that there is no conflict of interest.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study, informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jha, S.S., Srivastava, A., Kambhampati, S.B.S. et al. Introduction to Osteoporosis, Osteomalacia, and Fragility Fractures. JOIO 57 (Suppl 1), 25–32 (2023). https://doi.org/10.1007/s43465-023-01015-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-023-01015-0